首航高科(002665.SZ):擬投建山東肥城100MW/400MWH新型壓縮二氧化碳熔鹽儲能項目
格隆匯3月1日丨首航高科(002665.SZ)公佈,為加快新型儲能項目資源開發、投資、建設,首航高科能源技術股份有限公司(以下簡稱“公司”或“乙方”)與肥城經濟開發區管理委員會(以下簡稱“肥城經開區”或“甲方”)就新型熔鹽儲能領域合作簽訂《山東肥城100MW/400MWH新型壓縮二氧化碳熔鹽儲能項目投資協議》。公司將與肥城經開區下屬公司山東肥城經開建設集團有限公司共同出資設立合資公司,並以項目公司名義作為上述新型儲能項目的後續開發、投資、建設的主體。投資額度8億元;項目建設期限2024年-2025年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.